Buoyancy and Drug Release Patterns of Floating Minitablets Containing Piretanide and Atenolol as Model Drugs

References

• Timmermans J., Moës A. J. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. J. Pharm. Sci. 1994; 83: 18–24
   PubMed Web of Science ®Google Scholar
• Doelker E. Novel methods of producing controlled release hard gelatin capsules. Proceedings Capsugel Symposium. Hamburg 1988; 7–15
   Google Scholar
• Bongiovanni G., Calanchi M., Marconi M. Multiparticulate sustained release matrix system, International Patent Application. A61K9/48,9/20, 1–13, 1992
   Google Scholar
• Follonier N., Doelker E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. S. T. P. Pharma 1992; 2: 141–158
   Google Scholar
• Kawashima Y., Niwa T., Takeuchi H., Hino T., Itoh Y. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J. Controlled Release 1991; 16: 279–290
   Web of Science ®Google Scholar
• Icnikawa M., Kato T., Kawahara M., Watanabe S., Kayano M. A new multiple-unit oral floating dosage system. II: In vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs. J. Pharm. Sci. 1991; 80: 1153–1156
   PubMed Web of Science ®Google Scholar
• Ruhnke A. Einfluss der Dichte von Pellets auf die Verweildauer im Magen und die Absorption eines Modell-Arzneistoffes. Ph. D. Thesis, University of Hamburg. 1989
   Google Scholar
• Lippold B. C., Günther J. In-vivo Prüfung einer muitipartikularen Retard-Schwimmarzneiform. Eur. J. Pharm. Biopharm. 1991; 37: 254–261
   Web of Science ®Google Scholar
• Colombo P., Conte U., Caramella C., Gazzaniga A., La Manna A. Compressed polymeric mini-matrices for drug release control. J. Controlled Release 1985; 1: 283–289
   Google Scholar
• Gazzaniga A., Conte U., Sangalli M. E., Caramella C., La Manna A. A multiple unit modified release system. Polymers in Medicine III, C. Migliaresi, et al. Elsevier Science Publishers B.V., Amsterdam 1988; 201–208
   Google Scholar
• Rouge N., Cole E. T., Buri P., Doelker E. Screening of the potentially excipients for floating minitablets. S. T. P. Pharma 1997, in press
   Google Scholar
• Brockmeier D., Grigoleit H.-G., Heptner H., Meyer B. H. Kinetics of piretanide absorption from the gastrointestinal tract. Methods Find. Exp. Clin. Pharmacol. 1986; 8: 731–739
   PubMedGoogle Scholar
• Brockmeier D., Grigoleit H.-G., Leonhardt H. The absorption of piretanide from the gastro-intestinal tract is site-dependent. Eur. J. Clin. Pharmacol. 1986; 30: 79–82
   PubMed Web of Science ®Google Scholar
• Taylor D. C. Sites and mechanisms of intestinal drug absorption. Pharm. Int. 1986; 7: 179–183
   Google Scholar
• Rouge N., Buri P., Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. 1996; 136: 117–139
   Web of Science ®Google Scholar
• Rouge N., Leroux J. C., Cole E. T., Doelker E., Buri P. Prevention of the sticking tendency of the minitablets filled into hard gelatin capsules. Eur. J. Pharm. Biopharm. 1996; 43: 165–171
   Web of Science ®Google Scholar
• Timmermans J., Moës A. J. Apparatus and method for resultant-weight measuring system, US Patent Application. 5,076,107, 1991
   Google Scholar
• Timmermans J. Floating hydrophilic matrix dosage forms for oral use: factors controlling their buoyancy and gastric residence capabilities. Ph.D. Thesis, University of Brussels. 1991
   Google Scholar
• Uekama K., Matsubara K., Abe K., Horiuchi Y., Hirayama F., Suzuki N. Design and in vitro evaluation of slow-release dosage form of piretanide: utility of β-cyclodextrin: cellulose derivative combination as a modified-release drug carrier. J. Pharm. Sci. 1990; 79: 244–247
   PubMed Web of Science ®Google Scholar
• Doherty C., York P. Mechanisms of dissolution of furosemide/PVP solid dispersions. Int. J. Pharm. 1987; 34: 197–205
   Web of Science ®Google Scholar
• Peppas N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 1985; 60: 110–111
   PubMedGoogle Scholar
• Ritger P. L., Peppas N. A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable device. J. Controlled Release 1987; 5: 37–42
   Google Scholar
• Ostberg T., Lund E. M., Graffner C. Calcium alginate matrices for oral multiple unit administration: IV. Release characteristics in different media. Int. J. Pharm. 1994; 112: 241–248
   Web of Science ®Google Scholar
• Conte U., Maggi L., La Manna A. Swellable/erodible barriers for the modulation of drug release from hydrophilic matrices. Proc. Int. Symp. Controlled Release Bioact. Mater. 1994; 21: 60–61
   Google Scholar
• Doelker E. Water-swollen cellulose derivatives in pharmacy. Hydrogels in Medicine and Pharmacy, Vol. II: Polymers, N. A. Peppas. CRC Press, Boca Raton, FL 1987; 115–160
   Google Scholar
• Stockwell A. F., Davis S. S., Walker S. E. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J. Controlled Release 1986; 3: 167–175
   Google Scholar
• Krögel I., Bodmeier R. Evaluation of the floating properties of coated drug delivery systems containing effervescent excipient. Eur. J. Pharm. Biopharm. 1996; 42: 21
   Google Scholar
• Vazquez M. J., Seijas R. M., Gomez-Amoza J. L., Martinez-Pacheco R., Souto C., Concheiro A. Influence of dissolution medium and technological variables on release of atenolol from hydrophilic hydroxy-propylmethylcellulose. S. T. P. Pharma 1992; 2: 397–403
   Google Scholar